Virtual screening for potential inhibitors of homology modeled Leptospira interrogans MurD ligase
The life-threatening infections caused by Leptospira serovars remain a global challenge since long time. Prevention of infection by controlling environmental factors being difficult to practice in developing countries, there is a need for designing potent anti-leptospirosis drugs. ATP-dependent MurD involved in biosynthesis of peptidoglycan was identified as common drug target among pathogenic Leptospira serovars through subtractive genomic approach. Peptidoglycan biosynthesis pathway being unique to bacteria and absent in host represents promising target for antimicrobial drug discovery. Thus, MurD 3D models were generated using crystal structures of 1EEH and 2JFF as templates in Modeller9v7. Structural refinement and energy minimization of the model was carried out in Maestro 9.0 applying OPLS-AA 2001 force field and was evaluated through Procheck, ProSA, PROQ, and Profile 3D. The active site residues were confirmed from the models in complex with substrate and inhibitor. Four published MurD inhibitors (two phosphinics, one sulfonamide, and one benzene 1,3-dicarbixylic acid derivative) were queried against more than one million entries of Ligand.Info Meta-Database to generate in-house library of 1,496 MurD inhibitor analogs. Our approach of virtual screening of the best-ranked compounds with pharmacokinetics property prediction has provided 17 novel MurD inhibitors for developing anti-leptospirosis drug targeting peptidoglycan biosynthesis pathway.
KeywordsPeptidoglycan biosynthesis Leptospirosis Virtual high-throughput screening MurD inhibitors
The study was supported by grants from DBT, Ministry of Science and Technology, Government of India, New Delhi. We are grateful to Dr. B. Vengamma, Director, for providing constant support and encouragement for research at SVIMS Bioinformatics Centre, where this work has been performed. We thank Prof. S. Ramakumar, IISc., Bangalore for rendering critical valuable suggestions on the present work.
- 2.World Health Organization (1999) Leptospirosis worldwide. Wkly Epidemiol Rec 74:237–242Google Scholar
- 4.Trueba G, Zapata S, Madrid K, Cullen P, Haake D (2004) Cell aggregation: a mechanism of pathogenic Leptospira to survive in fresh water. Int Microbiol 7:35–40Google Scholar
- 6.Guidugli F, Castro AA, Atallah (2000) Antibiotics for preventing leptospirosis. Cochrane Database Syst Rev 4:CD001305Google Scholar
- 17.Maestro 9.0, versuib 70110, Schrodinger, New YorkGoogle Scholar
- 18.Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, Bairoch A (2005) Protein Identification and Analysis Tools on the ExPASy Server. In: John M. Walker (ed) The Proteomics Protocols Handbook. Humana Press, pp 571–607Google Scholar
- 21.Murzin AG, Brenner SE, Hubbard T, Chothia C (1995) SCOP: a structural classification of proteins database for the investigation of sequences and structures. J Mol Biol 247:536–540Google Scholar
- 26.Kotnik M, Humljan J, Contreras-Martel C, Oblak M, Kristan K, Hervé M, Blanot D, Urleb U, Gobec S, Dessen A, Solmajer T (2007) Structural and functional characterization of enantiomeric glutamic acid derivatives as potential transition state analogue inhibitors of MurD ligase. J Mol Biol 370:107–115CrossRefGoogle Scholar
- 34.Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE, Francis P, Shenkin PS (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739–1749CrossRefGoogle Scholar
- 35.Faine S, Adler B, Bolin C, Perolat P (1999) Appendix 2 Species and serovar list. In: Leptospira and leptospirosis, 2nd edn. Medisci, Melbourne, Australia, pp 138–139Google Scholar